Immediate Impact
56 standout
Citing Papers
Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Works of Jin Shu being referenced
Preclinical Mechanisms of Topical PRN473, a Bruton Tyrosine Kinase Inhibitor, in Immune-Mediated Skin Disease Models
2021
Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jin Shu | 108 | 84 | 37 | 82 | 18 | 268 | |
| Jean Vial | 123 | 66 | 46 | 51 | 28 | 294 | |
| Stefan Koehrer | 124 | 110 | 83 | 68 | 14 | 284 | |
| Cheng Liao | 74 | 123 | 36 | 60 | 12 | 257 | |
| Jennifer Postelnek | 86 | 78 | 100 | 39 | 12 | 267 | |
| Luke B. Fletcher | 165 | 68 | 63 | 41 | 16 | 319 | |
| Sandra Di Gregorio | 105 | 99 | 62 | 28 | 17 | 311 | |
| Valeria Di Maio | 95 | 124 | 52 | 101 | 25 | 294 | |
| Feili Chen | 99 | 48 | 53 | 92 | 17 | 251 | |
| Yanan Min | 74 | 54 | 43 | 45 | 12 | 293 | |
| Cecilia Arana Yi | 78 | 70 | 53 | 22 | 20 | 201 |
All Works
Login with ORCID to disown or claim papers
Loading papers...